
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer ...
Jan 16, 2024 · Summary: This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants on active …
Healthcare & Patient Services | Mount Sinai - New York
Mount Sinai Health System offers patients the full range of clinical care specialties and treatments, as well as a vast network of facilities.
Turning 18 Months into 18 Years | Mount Sinai - New York
When Bill was first informed of his advanced disease (Gleason Total Score 9, Grade T-3A) in 1995, the recommendation to go on hormone therapy with Lupron. In addition, Bill made dramatic lifestyle …
High Intensity Focused Ultrasound (HIFU) - Mount Sinai Health System
High-Intensity Focused Ultrasound or HIFU is a non-invasive heating procedure for treating localized prostate cancer.
Active Surveillance | Mount Sinai - New York
Active surveillance is most appropriate for you medically if: You aren’t experiencing any symptoms You have a slow-growing cancer (Gleason score of less than 6) Your cancer is small (cannot be seen on …
If you have cancer that is clinically insignifi cant (Gleason 6), we would recommend active surveillance. However, if there is clinically signifi cant cancer (any Gleason 7, more than 2 cores of Gleason 6 or …
Pathology Test Uses Artificial Intelligence to Predict Prostate Cancer ...
Oct 2, 2018 · A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following surgery, …
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma …
Dec 1, 2025 · - With a Gleason score of ≤6, treated within the last 24 months, or untreated and under surveillance - With a Gleason score of 3+4 that has been treated >6 months prior to full study …
Urologists use the Gleason Score grading system to determine appropriate treatment options based on the behavior of a prostate cancer.. The higher the score, the quicker the cancer will grow and spread …
A Study of BION-1301 in Adults With IgA Nephropathy
Jul 27, 2023 · Participants with low-risk prostate cancer (i.e., Gleason score < 7 and prostate specific antigen < 10 ng/mL) are allowed. - Pregnancy or breastfeeding or intent to become pregnant or to …